Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-04-03

FDA Approved: BACLOFEN — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved Teva's supplemental application for baclofen (generic), indicating an approval related to the product's labeling or formulation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BACLOFEN (Baclofen)

Snippet

SUPPL AP for BACLOFEN (BACLOFEN)